featured
Long-Term Efficacy and Safety of Sonidegib in Patients With Advanced Basal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Efficacy and Safety of Sonidegib in Patients With Advanced Basal Cell Carcinoma: 42-Month Analysis of the Phase 2 Randomised, Double-Blind BOLT Study
Br J Dermatol 2019 Sep 23;[EPub Ahead of Print], R Dummer, A Guminksi, R Gutzmer, JT Lear, KD Lewis, ALS Chang, P Combemale, L Dirix, M Kaatz, R Kudchadkar, C Loquai, R Plummer, HJ Schulze, AJ Stratigos, U Trefzer, N Squittieri, MR MigdenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.